Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.

The evolution of drug-resistance in pathogens is a major global health threat. Elucidating the molecular basis of pathogen drug-resistance has been the focus of many studies but rarely is it known whether a drug-resistance mechanism identified is universal for the studied pathogen; it has seldom bee...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Saskia Decuypere, Manu Vanaerschot, Kirstyn Brunker, Hideo Imamura, Sylke Müller, Basudha Khanal, Suman Rijal, Jean-Claude Dujardin, Graham H Coombs
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
Acceso en línea:https://doaj.org/article/3cc11c779a5c45b59e37c9791843ce84
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3cc11c779a5c45b59e37c9791843ce84
record_format dspace
spelling oai:doaj.org-article:3cc11c779a5c45b59e37c9791843ce842021-11-18T09:14:25ZMolecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.1935-27271935-273510.1371/journal.pntd.0001514https://doaj.org/article/3cc11c779a5c45b59e37c9791843ce842012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22389733/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735The evolution of drug-resistance in pathogens is a major global health threat. Elucidating the molecular basis of pathogen drug-resistance has been the focus of many studies but rarely is it known whether a drug-resistance mechanism identified is universal for the studied pathogen; it has seldom been clarified whether drug-resistance mechanisms vary with the pathogen's genotype. Nevertheless this is of critical importance in gaining an understanding of the complexity of this global threat and in underpinning epidemiological surveillance of pathogen drug resistance in the field. This study aimed to assess the molecular and phenotypic heterogeneity that emerges in natural parasite populations under drug treatment pressure. We studied lines of the protozoan parasite Leishmania (L.) donovani with differential susceptibility to antimonial drugs; the lines being derived from clinical isolates belonging to two distinct genetic populations that circulate in the leishmaniasis endemic region of Nepal. Parasite pathways known to be affected by antimonial drugs were characterised on five experimental levels in the lines of the two populations. Characterisation of DNA sequence, gene expression, protein expression and thiol levels revealed a number of molecular features that mark antimonial-resistant parasites in only one of the two populations studied. A final series of in vitro stress phenotyping experiments confirmed this heterogeneity amongst drug-resistant parasites from the two populations. These data provide evidence that the molecular changes associated with antimonial-resistance in natural Leishmania populations depend on the genetic background of the Leishmania population, which has resulted in a divergent set of resistance markers in the Leishmania populations. This heterogeneity of parasite adaptations provides severe challenges for the control of drug resistance in the field and the design of molecular surveillance tools for widespread applicability.Saskia DecuypereManu VanaerschotKirstyn BrunkerHideo ImamuraSylke MüllerBasudha KhanalSuman RijalJean-Claude DujardinGraham H CoombsPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 6, Iss 2, p e1514 (2012)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Saskia Decuypere
Manu Vanaerschot
Kirstyn Brunker
Hideo Imamura
Sylke Müller
Basudha Khanal
Suman Rijal
Jean-Claude Dujardin
Graham H Coombs
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
description The evolution of drug-resistance in pathogens is a major global health threat. Elucidating the molecular basis of pathogen drug-resistance has been the focus of many studies but rarely is it known whether a drug-resistance mechanism identified is universal for the studied pathogen; it has seldom been clarified whether drug-resistance mechanisms vary with the pathogen's genotype. Nevertheless this is of critical importance in gaining an understanding of the complexity of this global threat and in underpinning epidemiological surveillance of pathogen drug resistance in the field. This study aimed to assess the molecular and phenotypic heterogeneity that emerges in natural parasite populations under drug treatment pressure. We studied lines of the protozoan parasite Leishmania (L.) donovani with differential susceptibility to antimonial drugs; the lines being derived from clinical isolates belonging to two distinct genetic populations that circulate in the leishmaniasis endemic region of Nepal. Parasite pathways known to be affected by antimonial drugs were characterised on five experimental levels in the lines of the two populations. Characterisation of DNA sequence, gene expression, protein expression and thiol levels revealed a number of molecular features that mark antimonial-resistant parasites in only one of the two populations studied. A final series of in vitro stress phenotyping experiments confirmed this heterogeneity amongst drug-resistant parasites from the two populations. These data provide evidence that the molecular changes associated with antimonial-resistance in natural Leishmania populations depend on the genetic background of the Leishmania population, which has resulted in a divergent set of resistance markers in the Leishmania populations. This heterogeneity of parasite adaptations provides severe challenges for the control of drug resistance in the field and the design of molecular surveillance tools for widespread applicability.
format article
author Saskia Decuypere
Manu Vanaerschot
Kirstyn Brunker
Hideo Imamura
Sylke Müller
Basudha Khanal
Suman Rijal
Jean-Claude Dujardin
Graham H Coombs
author_facet Saskia Decuypere
Manu Vanaerschot
Kirstyn Brunker
Hideo Imamura
Sylke Müller
Basudha Khanal
Suman Rijal
Jean-Claude Dujardin
Graham H Coombs
author_sort Saskia Decuypere
title Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
title_short Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
title_full Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
title_fullStr Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
title_full_unstemmed Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
title_sort molecular mechanisms of drug resistance in natural leishmania populations vary with genetic background.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/3cc11c779a5c45b59e37c9791843ce84
work_keys_str_mv AT saskiadecuypere molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
AT manuvanaerschot molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
AT kirstynbrunker molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
AT hideoimamura molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
AT sylkemuller molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
AT basudhakhanal molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
AT sumanrijal molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
AT jeanclaudedujardin molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
AT grahamhcoombs molecularmechanismsofdrugresistanceinnaturalleishmaniapopulationsvarywithgeneticbackground
_version_ 1718420958374526976